First Episode Schizophrenia-Spectrum Disorders: What Clinicians Need to Know-Lecture Presentation

Video Transcription

Video Summary

In this video, Amy Cohen, the Associate Director for SMI Advisor and a clinical psychologist, introduces the SMI Advisor webinar on schizophrenia and spectrum disorders. The webinar aims to provide clinicians with information about evidence-based care for those living with serious mental illness. Dr. Delbert Robinson, a professor of psychiatry and molecular medicine at the Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, leads the webinar. He discusses the major findings from first-episode treatment studies, focusing on symptom outcomes and side effects in patients with schizophrenia spectrum disorders. The webinar also addresses the health risks associated with these disorders and strategies to minimize them. Dr. Robinson emphasizes the importance of early intervention and adherence to medication for first-episode patients. He highlights the benefits of specialized treatment models and shares data from the RAISE-ETP study that shows improved outcomes for patients who received specialized care. The webinar also emphasizes the need for ongoing monitoring and assessment of side effects and provides guidance on medication choices and dosing. Dr. Robinson concludes by discussing the high relapse rate among first-episode patients and the importance of engagement and adherence to long-term treatment.

Keywords

Amy Cohen

SMI Advisor

schizophrenia

spectrum disorders

evidence-based care

Dr. Delbert Robinson

first-episode treatment studies

specialized treatment models

RAISE-ETP study